Trial Profile
Paroxetine controlled release [Paxil in the treatment of symptomatic menopausal women following discontinuation of hormone therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary)
- Indications Menopausal syndrome; Menopause
- Focus Therapeutic Use
- 22 Dec 2005 New trial record.